chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Incident Details: Per a local clinic provider's email sent out on 9/1/22-"the monovalent mRNA COVID-19 vaccines are not authorized as booster doses for individuals 12 years of age and older. Any patients that are currently scheduled to receive a booster should wait until we have the bivalent booster on hand." The patient,  was seen in office on 9/2/22 and received a booster dose of the monovalent mRNA COVID-19 vaccine (pfizer) by *** in error as patients are now only supposed to receive the bivalent booster per Dr.'s email. Pt was due for booster at the time they received it, however the bivalent booster was not yet stocked at the pharmacy.  Possible Cause: Possible cause of the incident is that an email was sent out regarding the discontinuation  of monovalent covid boosters until the pharmacy receives the bivalent booster doses. This was overlooked by management and staff, as previous changes to clinic processes is usually discussed in a meeting. Also ?monovalent? and ?bivalent? are new terms that have not previously been used when discussing booster vaccines.
Age: 20.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Urticaria
Clinical narrative: No wheal formed on 1st dose; 2nd dose given and wheal formed on 2nd attempt
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Headache, Injection site pain, Oropharyngeal pain, Pain in extremity
Clinical narrative: I had tenderness at the injection site. The day after receiving the vaccine, I had joint pain in my right arm and lasted a few weeks. I tested positive via home test for COVID-19 on 09/05/2022. I had a sore throat, low grade fever, congestion, headache and runny nose. I contacted my doctor via an email but have not heard back from her. I am taking ALEVE for my symptoms.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: I had tenderness at the injection site. The day after receiving the vaccine, I had joint pain in my right arm and lasted a few weeks. I tested positive via home test for COVID-19 on 09/05/2022. I had a sore throat, low grade fever, congestion, headache and runny nose. I contacted my doctor via an email but have not heard back from her. I am taking ALEVE for my symptoms.
Age: 47.0
Sex: M
Vaccine: COVID19-2, FLU4
Symptoms: Loss of consciousness
Clinical narrative: Patient Passed out shortly after being vaccinated, was standing at pharmacy counter and collapsed, staff called 911 and the patient was taken to hospital Medical Center emergency room in ambulance
Age: 0.25
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13
Symptoms: Eye swelling, Rash, Swelling
Clinical narrative: Mom called office today 09/07/2022 to let us know she took patient to ER because patients' body was getting a rash  all over body and body was swollen with both eyes swollen shut.
Age: 29.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Urticaria
Clinical narrative: No wheal formed on 1st dose; 2nd dose given and wheal formed.
Age: 47.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Urticaria
Clinical narrative: No wheal formed on 1st dose; 2nd dose given and wheal formed
Age: 83.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, COVID-19, SARS-CoV-2 test positive
Clinical narrative: WEAKNESS.
Age: 51.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Urticaria
Clinical narrative: No wheal formed on the 1st dose attempt; 2nd dose given and wheal formed
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Vac inated pt admitted to hospital with positive covid infection. No information available on type of vaccine, date, or time of vaccination
Age: 44.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Urticaria
Clinical narrative: No wheal formed on 1st dose/attempt; 2nd dose given and wheal formed
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebral atrophy, Cognitive disorder, Communication disorder, Concussion, Dysarthria
Clinical narrative: Within days of this shot I experienced stroked like symptoms and had to have an MRI. Itook a hard fall inside our home and suffered a bad concussion. My speech was slurred, he could not put a sentence together. Before getting this shot we had both had COVID-19 and it did hit us both pretty hard.    Since I have had this shot my cognitive abilities have slowly declined and they have n explanations. My short term memory, my speech, my vision, and my hearing have all declined.   They have declined to a point to where some days I do not leave our bedroom. I have trouble recalling conversations or events that may have happened just a few hours earlier.   I have seen two Neurologist and a Neurosurgeon-  One MRI stated brain Atrophy in a July 2022 MRI
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Hypoacusis, Magnetic resonance imaging head abnormal, Memory impairment, Mobility decreased
Clinical narrative: Within days of this shot I experienced stroked like symptoms and had to have an MRI. Itook a hard fall inside our home and suffered a bad concussion. My speech was slurred, he could not put a sentence together. Before getting this shot we had both had COVID-19 and it did hit us both pretty hard.    Since I have had this shot my cognitive abilities have slowly declined and they have n explanations. My short term memory, my speech, my vision, and my hearing have all declined.   They have declined to a point to where some days I do not leave our bedroom. I have trouble recalling conversations or events that may have happened just a few hours earlier.   I have seen two Neurologist and a Neurosurgeon-  One MRI stated brain Atrophy in a July 2022 MRI
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Neurological symptom, Scan with contrast abnormal, Visual impairment
Clinical narrative: Within days of this shot I experienced stroked like symptoms and had to have an MRI. Itook a hard fall inside our home and suffered a bad concussion. My speech was slurred, he could not put a sentence together. Before getting this shot we had both had COVID-19 and it did hit us both pretty hard.    Since I have had this shot my cognitive abilities have slowly declined and they have n explanations. My short term memory, my speech, my vision, and my hearing have all declined.   They have declined to a point to where some days I do not leave our bedroom. I have trouble recalling conversations or events that may have happened just a few hours earlier.   I have seen two Neurologist and a Neurosurgeon-  One MRI stated brain Atrophy in a July 2022 MRI
Age: 28.0
Sex: M
Vaccine: COVID19-2
Symptoms: Arthralgia, Arthritis, Extra dose administered, Oedema peripheral, Walking aid user
Clinical narrative: About 12 hours after the shot I was laying in bed and got a sudden pain in my right knee. That night I took an ADVIL and iced it. At midnight I took TYLENOL. It was very severe I couldn't put weight on it and used a cane. I went to the Dr. the next morning and had to use a wheelchair. They wrapped my knee and gave me ibuprofen. That day it was severe and it's gotten progressively better.
Age: 28.0
Sex: M
Vaccine: COVID19-2
Symptoms: Weight bearing difficulty, Wheelchair user, X-ray limb abnormal
Clinical narrative: About 12 hours after the shot I was laying in bed and got a sudden pain in my right knee. That night I took an ADVIL and iced it. At midnight I took TYLENOL. It was very severe I couldn't put weight on it and used a cane. I went to the Dr. the next morning and had to use a wheelchair. They wrapped my knee and gave me ibuprofen. That day it was severe and it's gotten progressively better.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test positive, Upper-airway cough syndrome
Clinical narrative: I began to feel like I had a severe case of allergies. My nose was running, eyes were running, post nasal drip and I had a sore throat. I took an at home COVID 19 test that came back inclusive. I went to the local clinic on 09/06/2022 and they confirmed I was positive. They decided not to give any anti-viral medications due to my high blood pressure. Instead I picked up their recommendation of CORICIDIN cold and cough medicine.
Age: 27.0
Sex: U
Vaccine: SMALLMNK
Symptoms: Urticaria
Clinical narrative: No wheal formed on 1st dose/attempt. 2nd dose given; wheal form on 2nd attempt/dose
Age: 43.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dysphagia, Swollen tongue, Tongue disorder
Clinical narrative: Difficulty swallowing and tongue felt swollen or not working.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Vaccinated pt admitted with postive covid infection
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cough, Fatigue, Feeling abnormal, Headache
Clinical narrative: In the evening of the 4th I started feeling like I had a head cold kinda thing with congestion, nasal drip, and headache. Woke up the next morning and was still feeling bad and we were supposed to go out of town that day and I decided to do a home COVID-19 test and it was positive and I called a telehealth for a visit and the RNP prescribed PAXLOVID and I started taking it that immediately that evening. That evening I started experiencing fatigue and feeling worse and the symptoms started feeling minor and on the 11th I was still feeling fatigue and on the 12th I was normal and on the 13th I started feeling the rebound symptoms with fatigue, cough, congestion. I also ran fever and a funny taste in my mouth and it was odd there for awhile. It finally started to trail off over awhile and I would say that about the 25th I started feeling like doing anything. I monitored my blood oxygen level and blood pressure and still have a lingering cough.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Nasopharyngitis, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive, Sinus operation
Clinical narrative: In the evening of the 4th I started feeling like I had a head cold kinda thing with congestion, nasal drip, and headache. Woke up the next morning and was still feeling bad and we were supposed to go out of town that day and I decided to do a home COVID-19 test and it was positive and I called a telehealth for a visit and the RNP prescribed PAXLOVID and I started taking it that immediately that evening. That evening I started experiencing fatigue and feeling worse and the symptoms started feeling minor and on the 11th I was still feeling fatigue and on the 12th I was normal and on the 13th I started feeling the rebound symptoms with fatigue, cough, congestion. I also ran fever and a funny taste in my mouth and it was odd there for awhile. It finally started to trail off over awhile and I would say that about the 25th I started feeling like doing anything. I monitored my blood oxygen level and blood pressure and still have a lingering cough.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: SOB
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Headache, Oropharyngeal pain, SARS-CoV-2 test positive, Vomiting
Clinical narrative: Developed sore throat, headache and vomiting. Tested COVID-19 positive on rapid antigen test 9/7/2022.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray normal, Cough, Dyspnoea, Hypoxia
Clinical narrative: an 83-year-old female with a history of advanced COPD with Pseudomonas colonization, hypertension, dyslipidemia, GERD and osteoporosis, who presented with increasing shortness of breath, cough and hypoxia on 08/24.  At the time of admission, chest x-ray was negative for infiltrate.  Patient is fully vaccinated against COVID, however COVID test was positive on 08/24.  Patient was placed in severe respiratory isolation.  Patient was continued on Spiriva, Symbicort and DuoNebs.  The patient also is on daily azithromycin and alternating colistin/TOBI treatments.  Patient was continued on colistin.  Patient had been started on Prednisone prior to admission, which was transitioned to IV Solumedrol.  Patient was also started on Remdesivir.  Pulmonary was consulted.  She was continued on IV Remdesivir (completed 5 days), breathing treatments as well as steroids with slow improvement in her respiratory status.  She was transitioned back to prednisone on 08/29.  As the patient had clinically improved, having completed treatment with remdesivir, and being transitioned to oral prednisone she was discharged to home on 8/30/22.  She was seen by pulmonary rehab on day of discharge, and will require 2 L oxygen with activity only.   She will be discharged home on 8/30/22.  She will be placed on a tapering dose of Prednisone at discharge, and should follow-up with her PCP in 1 week.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: an 83-year-old female with a history of advanced COPD with Pseudomonas colonization, hypertension, dyslipidemia, GERD and osteoporosis, who presented with increasing shortness of breath, cough and hypoxia on 08/24.  At the time of admission, chest x-ray was negative for infiltrate.  Patient is fully vaccinated against COVID, however COVID test was positive on 08/24.  Patient was placed in severe respiratory isolation.  Patient was continued on Spiriva, Symbicort and DuoNebs.  The patient also is on daily azithromycin and alternating colistin/TOBI treatments.  Patient was continued on colistin.  Patient had been started on Prednisone prior to admission, which was transitioned to IV Solumedrol.  Patient was also started on Remdesivir.  Pulmonary was consulted.  She was continued on IV Remdesivir (completed 5 days), breathing treatments as well as steroids with slow improvement in her respiratory status.  She was transitioned back to prednisone on 08/29.  As the patient had clinically improved, having completed treatment with remdesivir, and being transitioned to oral prednisone she was discharged to home on 8/30/22.  She was seen by pulmonary rehab on day of discharge, and will require 2 L oxygen with activity only.   She will be discharged home on 8/30/22.  She will be placed on a tapering dose of Prednisone at discharge, and should follow-up with her PCP in 1 week.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Per Dr.'s email sent out on 9/1/22-"the monovalent mRNA COVID-19 vaccines are not authorized as booster doses for individuals 12 years of age and older. Any patients that are currently scheduled to receive a booster should wait until we have the bivalent booster on hand." The patient, was seen in office on 9/2/22 and received a booster dose of the monovalent mRNA COVID-19 vaccine (pfizer) by nurse in error as patients are now only supposed to receive the bivalent booster per Dr.'s email. Pt was due for booster at the time they received it, however the bivlalent booster was not yet stocked at facility.  Possible cause of the incident is that an email was sent out regarding the discontinuation  of monovalent covid boosters until facility receives the bivalent booster doses. This was overlooked by management and staff, as previous changes to clinic processes is usually discussed in a meeting. Also ?monovalent? and ?bivalent? are new terms that have not previously been used when discussing booster vaccines.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, SARS-CoV-2 test positive
Clinical narrative: 9/6/22 developed a temp, tested positive on Abbott ID Now molecular test- had known covid exposure
Age: 30.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Patient was to receive Pfizer primary series dose 2; but was inadvertently given the Pfizer bivalent dose instead. Provider onsite was notified and  Patient was notified of error.  Pt was monitored and remained stable with no s/sxs of side effects.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Vaccinated pt admitted to hospital with covid infection. Unknown date, manufacturer and all other vaccine info. Pt reported vaccination status and no further information is available
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Underdose
Clinical narrative: THE VACCINE ADMINISTERED WAS FOR 2 TO LESS THAN 5 YEARS OLD GIVE TO A 5 YEARS OLD CHILD
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Alcohol poisoning, Asymptomatic COVID-19, Blood ethanol increased, Blood lactic acid, COVID-19
Clinical narrative: PRESENTING PROBLEM: Acute alcohol intoxication, with unspecified complication (HCC) [F10.929] Alcoholic intoxication without complication (HCC) [F10.920] Community acquired pneumonia of right lower lobe of lung [J18.9] COVID-19 virus detected [U07.1]   HOSPITAL COURSE: The patient is a 67-year-old female with history of dementia and alcohol abuse who presented to the emergency department acutely intoxicated from her independent living facility.  Labs were stable in the emergency department.  Lactic acid was elevated to 3.1.  The patient was positive for COVID.  Ethanol level was 426. Chest x-ray showed a right basilar lung opacity.  IV antibiotics were started.  The patient was admitted for further continuation of care.  Antibiotics were stopped on admission.  The patient's procalcitonin level was unremarkable.  CT head was negative for an acute process.  Her mentation improved.  She was alert and oriented x4 the day of discharge.  Her lactic acidosis resolved with IV fluid hydration. She was asymptomatic from a COVID-19 perspective.  Social work evaluated the patient.  She was discharged back to independent living in stable condition.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Computerised tomogram head normal, Laboratory test normal, Lactic acidosis, Lung opacity
Clinical narrative: PRESENTING PROBLEM: Acute alcohol intoxication, with unspecified complication (HCC) [F10.929] Alcoholic intoxication without complication (HCC) [F10.920] Community acquired pneumonia of right lower lobe of lung [J18.9] COVID-19 virus detected [U07.1]   HOSPITAL COURSE: The patient is a 67-year-old female with history of dementia and alcohol abuse who presented to the emergency department acutely intoxicated from her independent living facility.  Labs were stable in the emergency department.  Lactic acid was elevated to 3.1.  The patient was positive for COVID.  Ethanol level was 426. Chest x-ray showed a right basilar lung opacity.  IV antibiotics were started.  The patient was admitted for further continuation of care.  Antibiotics were stopped on admission.  The patient's procalcitonin level was unremarkable.  CT head was negative for an acute process.  Her mentation improved.  She was alert and oriented x4 the day of discharge.  Her lactic acidosis resolved with IV fluid hydration. She was asymptomatic from a COVID-19 perspective.  Social work evaluated the patient.  She was discharged back to independent living in stable condition.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pneumonia, Procalcitonin normal, SARS-CoV-2 test positive
Clinical narrative: PRESENTING PROBLEM: Acute alcohol intoxication, with unspecified complication (HCC) [F10.929] Alcoholic intoxication without complication (HCC) [F10.920] Community acquired pneumonia of right lower lobe of lung [J18.9] COVID-19 virus detected [U07.1]   HOSPITAL COURSE: The patient is a 67-year-old female with history of dementia and alcohol abuse who presented to the emergency department acutely intoxicated from her independent living facility.  Labs were stable in the emergency department.  Lactic acid was elevated to 3.1.  The patient was positive for COVID.  Ethanol level was 426. Chest x-ray showed a right basilar lung opacity.  IV antibiotics were started.  The patient was admitted for further continuation of care.  Antibiotics were stopped on admission.  The patient's procalcitonin level was unremarkable.  CT head was negative for an acute process.  Her mentation improved.  She was alert and oriented x4 the day of discharge.  Her lactic acidosis resolved with IV fluid hydration. She was asymptomatic from a COVID-19 perspective.  Social work evaluated the patient.  She was discharged back to independent living in stable condition.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Asymptomatic COVID-19, COVID-19, Gastrointestinal haemorrhage, SARS-CoV-2 test positive
Clinical narrative: Asymptomatic: Tested COVID-19 positive on routine admission screening test. Admitted 9/6/2022 following hospital stay r/t GI bleed.
Age: 66.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: SOB
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Vaccinated pt (per family) admitted with covid infection. Unknown vaccine manufacturer/date/time/place etc.
Age: 30.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Rash macular, Rash pruritic
Clinical narrative: red splotchy itchy
Age: 39.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Wrong technique in product usage process
Clinical narrative: no wheel created on first attempt to administer intradermal vaccine. a second attempt was made on right arm and was successful
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: TINNITUS - NOTED RINGING IN EARS BUT ATTRIBUTED TO POSSIBLE ALLERGIES (EVEN THOUGH IT WAS NOT NORMAL TIMING.)  A FEW DAYS AFTER RECEIVING MY SECOND VACCINATION ON 09/08/2021 I NOTED THE RINGING HAD INTENSIFIED.  STILL DID NOT ATTRIBUTE TO A REACTION OF THE VACCINE, BUT DID NOTE THE TIMING WAS CLOSELY RELATED TO DATES OF VACCINE ADMINISTRATION.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cardiac stress test normal, Chest pain, Chronic obstructive pulmonary disease, Computerised tomogram thorax abnormal
Clinical narrative: Patient ID: 76 y.o.    Admit Date:  8/2/2022   Discharge Date: 8/6/22   Principal Dx/ Final Dx: Precordial chest pain   Relevant Inpt Dx: Principal Problem:   Precordial chest pain Active Problems:   COVID-19 virus infection   COPD (chronic obstructive pulmonary disease)       HPI:   Hospital Course:   This 76 year old man was admitted with chest pain and covid.   He ruled out for MI.  D-dimer was normal.  He had stress test that showed no ischemia and echo that showed normal LVEF.   He had covid and copd.  He was treated with remdesivir and steroids and nebs.  He has improved.  Today his lungs have no wheezing.  He will complete oral steroids.  He does have home oxygen and will continue this   He did have CT that showed possible right apical lung mass and right renal lesion.  Will arrange repeat imaging in several weeks and follow up with pcp, pulmonary, and urology.  He does have hepatic lesions that have been present since 2017 and this will follow up on those also.             Consults:   IP CONSULT TO CARDIOLOGY IP CONSULT TO SOCIAL WORK IP CONSULT TO COPD NAVIGATOR       Disposition:  home   Discharge Condition:  fair
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Echocardiogram normal, Ejection fraction, Fibrin D dimer normal
Clinical narrative: Patient ID: 76 y.o.    Admit Date:  8/2/2022   Discharge Date: 8/6/22   Principal Dx/ Final Dx: Precordial chest pain   Relevant Inpt Dx: Principal Problem:   Precordial chest pain Active Problems:   COVID-19 virus infection   COPD (chronic obstructive pulmonary disease)       HPI:   Hospital Course:   This 76 year old man was admitted with chest pain and covid.   He ruled out for MI.  D-dimer was normal.  He had stress test that showed no ischemia and echo that showed normal LVEF.   He had covid and copd.  He was treated with remdesivir and steroids and nebs.  He has improved.  Today his lungs have no wheezing.  He will complete oral steroids.  He does have home oxygen and will continue this   He did have CT that showed possible right apical lung mass and right renal lesion.  Will arrange repeat imaging in several weeks and follow up with pcp, pulmonary, and urology.  He does have hepatic lesions that have been present since 2017 and this will follow up on those also.             Consults:   IP CONSULT TO CARDIOLOGY IP CONSULT TO SOCIAL WORK IP CONSULT TO COPD NAVIGATOR       Disposition:  home   Discharge Condition:  fair
Age: 0.92
Sex: M
Vaccine: TDAP
Symptoms: Medication error, Product administered to patient of inappropriate age, Skin abrasion
Clinical narrative: Medication error- 11 month old received TDap vaccine in ER. The patient had an abrasion over the left eye that the ER physician felt needed tetanus. The product is labeled for age 7 and up.
Age: 53.0
Sex: F
Vaccine: COVID19-2
Symptoms: Retinal haemorrhage
Clinical narrative: less than an hour after receiving the vaccine, I experienced a retinal bleed
Age: 4.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Administering nurse errored by drawing vaccine from adult vile. As such, dosage administered for patent's second vaccine was 50mcg/0.25mL rather than stipulated dose of 25mcg/0.25mL.
Age: 4.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Patient was given 50mcg/0.25mL of adult moderna instead of pediatric moderna vaccine. Patient did not experience any symptoms after vaccine administration.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asymptomatic COVID-19, SARS-CoV-2 test positive, Suicidal ideation
Clinical narrative: Pt here for suicidal ideation. Pt needed inpatient psychiatric care, but had to be tested for COVID before placement and was positive. Pt asymptomatic.
Age: 5.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Incorrect product formulation administered
Clinical narrative: Administering nurse, errored in drawing vaccine from adult vile.  As such, dose administered was 50mcg/0.25mL rather than stipulated pediatric dose of 25mcg/0.25mL.
Age: 2.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient was given 50mcg/0.25mL of adult moderna instead of pediatric moderna vaccine. Patient did not experience any symptoms after vaccine administration.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient was given 5-11 year old formulation and was 12 years old when vaccinated.  Mother was informed of error today, 9/7/2022, by this reporter and discussed plan to vaccinated with age appropriate dose at recommended interval.
Age: 43.0
Sex: F
Vaccine: SMALLMNK
Symptoms: Wrong technique in product usage process
Clinical narrative: no wheel created on 1st attempt to administer vaccine. 2nd attempt was successful on right arm
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Demyelinating polyneuropathy, Inflammation
Clinical narrative: patient was admitted on 8-15-22 with weakness which was found to be acute inflammatory demyelinating polyneuropathy. The patient was then transferred to the Inpatient rehab unit on 8-30-22.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, HEPA
Symptoms: Alanine aminotransferase increased, Aspartate aminotransferase increased, Asthma, Blood bilirubin increased, Condition aggravated
Clinical narrative: Moved on June 2022. On 8/8/22 rec'd quadracel and vaqta. 24 hours after vaccination developed scleral icterus, loss of appetite, and lethargy. Seen in office on 8/10/22. Found to have scleral icterus. Labs drawn and shown elevated AST, ALT, and bilirubin. Hepatitis panel and G6PD drawn and were negative/normal. By 8/11/22 was clinically doing better. Eating and playing usual amounts. No medications had been given. 8/12/22 was seen in office and clinically was normal. Labs showed decreasing liver enzymes. Was admitted for asthma exacerbation on 8/22/22 for 24 hours.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, HEPA
Symptoms: Decreased appetite, Hepatic enzyme decreased, Hepatitis viral test negative, Lethargy, Ocular icterus
Clinical narrative: Moved on June 2022. On 8/8/22 rec'd quadracel and vaqta. 24 hours after vaccination developed scleral icterus, loss of appetite, and lethargy. Seen in office on 8/10/22. Found to have scleral icterus. Labs drawn and shown elevated AST, ALT, and bilirubin. Hepatitis panel and G6PD drawn and were negative/normal. By 8/11/22 was clinically doing better. Eating and playing usual amounts. No medications had been given. 8/12/22 was seen in office and clinically was normal. Labs showed decreasing liver enzymes. Was admitted for asthma exacerbation on 8/22/22 for 24 hours.
Age: 82.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, COVID-19, Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: SOB, WEAKNESS
Age: 91.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Death, Paranasal sinus hypersecretion, SARS-CoV-2 test positive
Clinical narrative: pt had a positive COVID test on 2/14/22 in a nursing home; only sx were mild sinus drainage; pt in hospice care; passed away in the nursing home
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Incident Details: Per Dr.'s email sent out on 9/1/22-"the monovalent mRNA COVID-19 vaccines are not authorized as booster doses for individuals 12 years of age and older. Any patients that are currently scheduled to receive a booster should wait until we have the bivalent booster on hand." The patient, was seen in office on 9/2/22 and received a booster dose of the monovalent mRNA COVID-19 vaccine (pfizer) by nurse in error as patients are now only supposed to receive the bivalent booster per Dr.'s email. Pt was due for booster at the time they received it, however the bivlalent booster was not yet stocked at facility. Possible Cause: Possible cause of the incident is that an email was sent out regarding the discontinuation  of monovalent covid boosters until facility receives the bivalent booster doses. This was overlooked by management and staff, as previous changes to clinic processes is usually discussed in a meeting. Also ?monovalent? and ?bivalent? are new terms that have not previously been used when discussing booster vaccines.  Corrective Action: Corrective action included notifying staff and providers of the recent change regarding COVID vaccines and were notified to stop giving COVID booster doses until the Clinic receives the bivalent vaccines. Staff and providers were notified via email, skype, and verbally. Incident reported to VAERS. Recommendation: I would recommend holding a meeting to notify Leads/Supervisors/Managers of any changes regarding COVID vaccine administration, rather than sending out an email that may not be read by all staff. If an email is needed to be sent, I recommend making it clear that a process is being changed.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Incident Details: Per Dr's email sent out on 9/1/22-"the monovalent mRNA COVID-19 vaccines are not authorized as booster doses for individuals 12 years of age and older. Any patients that are currently scheduled to receive a booster should wait until we have the bivalent booster on hand." The patient, was seen in office on 9/2/22 and received a booster dose of the monovalent mRNA COVID-19 vaccine (pfizer) by employee in error as patients are now only supposed to receive the bivalent booster per Dr's email. Pt was due for booster at the time they received it, however the bivlalent booster was not yet stocked. Possible Cause: Possible cause of the incident is that an email was sent out regarding the discontinuation  of monovalent covid boosters until office receives the bivalent booster doses. This was overlooked by management and staff, as previous changes to clinic processes is usually discussed in a meeting. Also ?monovalent? and ?bivalent? are new terms that have not previously been used when discussing booster vaccines.  Corrective Action: Corrective action included notifying staff and providers of the recent change regarding COVID vaccines and were notified to stop giving COVID booster doses until the Vancouver Clinic receives the bivalent vaccines. Staff and providers were notified via email, skype, and verbally. Incident reported to VAERS. Recommendation: I would recommend holding a meeting to notify Leads/Supervisors/Managers of any changes regarding COVID vaccine administration, rather than sending out an email that may not be read by all staff. If an email is needed to be sent, I recommend making it clear that a process is being changed.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Feeling hot, Hyperhidrosis, Hypotension, Seizure like phenomena
Clinical narrative: Upon arriving for vaccine, patient and mother voiced his nervousness about vaccines.  Administering nurse used precautions after vaccine administration by laying patient back for 10 minutes.  Patient was conscious throughout this observation period and after 10 minutes felt well enough.  Nurse sat him up for an additional 5 minutes to monitor.  He sat in chair beside exam table while sibling received vaccination.  While sitting there, patient was verbal and playing on cell phone.  After sibling was observed for 10 minutes, patient then complained of feeling hot.  Mother provided him with water and after taking a few sips, his upper body began with light tremors, stopped, and then he was noted to be in a blank stare - all lasting about 30 seconds. Provider was called into the room.  Mother denied history or seizures.  Vitals were obtained.  No LOC occurred.  Patient was oriented and answering questions.  BP was reportedly low.  Consulted provider reported AOx3, with reports of dizziness and sweats.  Hypotensive at 77/45, tachycardic at 109, POX 99%.  Brief neurologic, cardiac, and pulm exam were within normal limits.  positioned supine with feet elevated.  Given water, crackers, and candy.  Repeat BP was 86/51, HR 54, then 93/57, HR 66. Decision by provider was to transport patient to ED for further evaluation with seizure like reaction.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Staring, Tachycardia, Tremor
Clinical narrative: Upon arriving for vaccine, patient and mother voiced his nervousness about vaccines.  Administering nurse used precautions after vaccine administration by laying patient back for 10 minutes.  Patient was conscious throughout this observation period and after 10 minutes felt well enough.  Nurse sat him up for an additional 5 minutes to monitor.  He sat in chair beside exam table while sibling received vaccination.  While sitting there, patient was verbal and playing on cell phone.  After sibling was observed for 10 minutes, patient then complained of feeling hot.  Mother provided him with water and after taking a few sips, his upper body began with light tremors, stopped, and then he was noted to be in a blank stare - all lasting about 30 seconds. Provider was called into the room.  Mother denied history or seizures.  Vitals were obtained.  No LOC occurred.  Patient was oriented and answering questions.  BP was reportedly low.  Consulted provider reported AOx3, with reports of dizziness and sweats.  Hypotensive at 77/45, tachycardic at 109, POX 99%.  Brief neurologic, cardiac, and pulm exam were within normal limits.  positioned supine with feet elevated.  Given water, crackers, and candy.  Repeat BP was 86/51, HR 54, then 93/57, HR 66. Decision by provider was to transport patient to ED for further evaluation with seizure like reaction.
Age: 70.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, Fatigue, SARS-CoV-2 test positive
Clinical narrative: WEAKNESS AND FATIGUE
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: ADMINISTERED EXPIRED VACCINE.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Incident Details: Per Dr. email sent out on 9/1/22-"the monovalent mRNA COVID-19 vaccines are not authorized as booster doses for individuals 12 years of age and older. Any patients that are currently scheduled to receive a booster should wait until we have the bivalent booster on hand." The patient, was seen in office on 9/6/22 and received a booster dose of the monovalent mRNA COVID-19 vaccine (pfizer) in error as patients are now only supposed to receive the bivalent booster per Dr. email. Pt was due for booster at the time they received it, however the bivlalent booster was not yet stocked at clinic. Possible Cause: Possible cause of the incident is that an email was sent out regarding the discontinuation  of monovalent covid boosters until clinic receives the bivalent booster doses. This was overlooked by management and staff, as previous changes to clinic processes is usually discussed in a meeting. Also ?monovalent? and ?bivalent? are new terms that have not previously been used when discussing booster vaccines.  Corrective Action: Corrective action included notifying staff and providers of the recent change regarding COVID vaccines and were notified to stop giving COVID booster doses until the Clinic receives the bivalent vaccines. Staff and providers were notified via email, skype, and verbally. Incident reported to VAERS. Recommendation: I would recommend holding a meeting to notify Leads/Supervisors/Managers of any changes regarding COVID vaccine administration, rather than sending out an email that may not be read by all staff. If an email is needed to be sent, I recommend making it clear that a process is being changed.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Incident Details: Per Drs. email sent out on 9/1/22- 'the monovalent mRNA COVID-19 vaccines are not authorized as booster doses for individuals 12 years of age and older. Any patients that are currently scheduled to receive a booster should wait until we have the bivalent booster on hand'. The patient was seen in office on 9/2/22 and received a booster dose of the monovalent mRNA COVID-19 vaccine (Pfizer) by staff in error as patients are now only supposed to receive the bivalent booster per Drs. email. Patient was due for booster at the time they received it, however the bivalent booster was not yet stocked. Possible Cause: Possible cause of the incident is that an email was sent out regarding the discontinuation of monovalent Covid boosters until Private receives the bivalent booster doses. This was overlooked by management and staff, as previous changes to clinic processes is usually discussed in a meeting. Also 'monovalent' and 'bivalent' are new terms that have not previously been used when discussing booster vaccines.  Corrective Action: Corrective action included notifying staff and providers of the recent change regarding COVID vaccines and were notified to stop giving COVID booster doses until the Clinic receives the bivalent vaccines. Staff and providers were notified via email, skype, and verbally. Incident reported to VAERS. Recommendation: I would recommend holding a meeting to notify Leads/Supervisors/Managers of any changes regarding COVID vaccine administration, rather than sending out an email that may not be read by all staff. If an email is needed to be sent, I recommend making it clear that a process is being changed.
Age: 4.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Ear infection, Fatigue, Immunisation reaction, Lethargy
Clinical narrative: -- Lethargic, 84 hours -- Fever over 103 F, 84 hours -- Fever over 104.5 F, 12 hours -- Vomiting all foods, liquids, and medicines, 84 hours -- All foods taste bad, still has symptom -- No appetite, still has symptom -- White "Covid" tongue, still has symptom -- Nausea, 84 hours -- Fatigue, 84 hours -- Ear infection, unknown duration
Age: 4.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Taste disorder, Tongue discolouration, Vomiting
Clinical narrative: -- Lethargic, 84 hours -- Fever over 103 F, 84 hours -- Fever over 104.5 F, 12 hours -- Vomiting all foods, liquids, and medicines, 84 hours -- All foods taste bad, still has symptom -- No appetite, still has symptom -- White "Covid" tongue, still has symptom -- Nausea, 84 hours -- Fatigue, 84 hours -- Ear infection, unknown duration
Age: 67.0
Sex: F
Vaccine: FLUA4
Symptoms: Chemotherapy, Eye swelling, Peripheral swelling
Clinical narrative: Patient woke up on Monday, 09/05/22, morning reporting that her hands were swollen and eyes were also swollen. Patient stated that her throat did not close. Patient states that symptoms began to disappear on Tuesday 09/06/22.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Incident Details: Per Drs. email sent out on 9/1/22- "the monovalent mRNA COVID-19 vaccines are not authorized as booster doses for individuals 12 years of age and older. Any patients that are currently scheduled to receive a booster should wait until we have the bivalent booster on hand". The patient was seen in office on 9/1/22 and received a booster dose of the monovalent mRNA COVID-19 vaccine (Pfizer) in error as patients are now only supposed to receive the bivalent booster per Drs. email. Patient was due for booster at the time they received it, however the bivalent booster was not yet stocked. Possible Cause: Possible cause of the incident is that an email was sent out regarding the discontinuation of monovalent Covid boosters until Private receives the bivalent booster doses. This was overlooked by management and staff, as previous changes to clinic processes is usually discussed in a meeting. Also 'monovalent' and 'bivalent' are new terms that have not previously been used when discussing booster vaccines.  Corrective Action: Corrective action included notifying staff and providers of the recent change regarding COVID vaccines and were notified to stop giving COVID booster doses until the Clinic receives the bivalent vaccines. Staff and providers were notified via email, skype, and verbally. Incident reported to VAERS. Recommendation: I would recommend holding a meeting to notify Leads/Supervisors/Managers of any changes regarding COVID vaccine administration, rather than sending out an email that may not be read by all staff. If an email is needed to be sent, I recommend making it clear that a process is being changed.
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered expired vaccine.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Asthenia, COVID-19, Cough, Death
Clinical narrative: 2/6 - 2/7/22 pt in Hospital with sx of cough, congestion, poor oral intake, SOB, weakness, AMS, nausea, body aches; positive COVID test, acute renal failure; DNR/DNI; family decided to transition pt to hospice; dc'd to home where pt passed away
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Hypophagia, Mental status changes, Nausea, Pain
Clinical narrative: 2/6 - 2/7/22 pt in Hospital with sx of cough, congestion, poor oral intake, SOB, weakness, AMS, nausea, body aches; positive COVID test, acute renal failure; DNR/DNI; family decided to transition pt to hospice; dc'd to home where pt passed away
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: 2/6 - 2/7/22 pt in Hospital with sx of cough, congestion, poor oral intake, SOB, weakness, AMS, nausea, body aches; positive COVID test, acute renal failure; DNR/DNI; family decided to transition pt to hospice; dc'd to home where pt passed away
Age: 13.0
Sex: M
Vaccine: MNQ
Symptoms: Syringe issue
Clinical narrative: Syringe broke during administration and only 1/2 dose was given.
Age: 7.0
Sex: M
Vaccine: DTAPIPV
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Patient was given Kinrix after the age of 7
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Incident Details: Per Dr.'s email sent out on 9/1/22-"the monovalent mRNA COVID-19 vaccines are not authorized as booster doses for individuals 12 years of age and older. Any patients that are currently scheduled to receive a booster should wait until we have the bivalent booster on hand." The patient, was seen in office on 9/2/22 and received a booster dose of the monovalent mRNA COVID-19 vaccine (pfizer) by nurse in error as patients are now only supposed to receive the bivalent booster per Dr.'s email. Pt was due for booster at the time they received it, however the bivlalent booster was not yet stocked at facility. Possible Cause: Possible cause of the incident is that an email was sent out regarding the discontinuation  of monovalent covid boosters until facility receives the bivalent booster doses. This was overlooked by management and staff, as previous changes to clinic processes is usually discussed in a meeting. Also ?monovalent? and ?bivalent? are new terms that have not previously been used when discussing booster vaccines.  Corrective Action: Corrective action included notifying staff and providers of the recent change regarding COVID vaccines and were notified to stop giving COVID booster doses until the Clinic receives the bivalent vaccines. Staff and providers were notified via email, skype, and verbally. Incident reported to VAERS. Recommendation: I would recommend holding a meeting to notify Leads/Supervisors/Managers of any changes regarding COVID vaccine administration, rather than sending out an email that may not be read by all staff. If an email is needed to be sent, I recommend making it clear that a process is being changed.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute myocardial infarction, Acute respiratory failure, Aortic aneurysm repair, COVID-19
Clinical narrative: + covid 7/21/2022;  admitted 7/23/22 altered mental status, had  mild confusion after AAA repair 7/6/22 but worsened the last few days prior to admission .  covid infusion? 7/22.     Pneumonia.  given roephin, azithromycin, decadron and later vancomycin and zosyn.  CT showed indeterminate age infarct  & chronic small vessel ischemic disease tPA not recommended, had carotid artery disease.  Statins held due to transaminitis.  transfered to ICU d/t acute resp failure s/p cardiac arrest apparently on 7/25/22 and he had ROSC, placed on ventilator, levophed.  AKI, AGMA,    did not improve and expired 7/30/22
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Cardiac arrest, Cerebral small vessel ischaemic disease, Computerised tomogram abnormal, Confusional state, Death
Clinical narrative: + covid 7/21/2022;  admitted 7/23/22 altered mental status, had  mild confusion after AAA repair 7/6/22 but worsened the last few days prior to admission .  covid infusion? 7/22.     Pneumonia.  given roephin, azithromycin, decadron and later vancomycin and zosyn.  CT showed indeterminate age infarct  & chronic small vessel ischemic disease tPA not recommended, had carotid artery disease.  Statins held due to transaminitis.  transfered to ICU d/t acute resp failure s/p cardiac arrest apparently on 7/25/22 and he had ROSC, placed on ventilator, levophed.  AKI, AGMA,    did not improve and expired 7/30/22
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Hypertransaminasaemia, Intensive care, Mechanical ventilation, Mental status changes, Metabolic acidosis
Clinical narrative: + covid 7/21/2022;  admitted 7/23/22 altered mental status, had  mild confusion after AAA repair 7/6/22 but worsened the last few days prior to admission .  covid infusion? 7/22.     Pneumonia.  given roephin, azithromycin, decadron and later vancomycin and zosyn.  CT showed indeterminate age infarct  & chronic small vessel ischemic disease tPA not recommended, had carotid artery disease.  Statins held due to transaminitis.  transfered to ICU d/t acute resp failure s/p cardiac arrest apparently on 7/25/22 and he had ROSC, placed on ventilator, levophed.  AKI, AGMA,    did not improve and expired 7/30/22
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia, SARS-CoV-2 test positive
Clinical narrative: + covid 7/21/2022;  admitted 7/23/22 altered mental status, had  mild confusion after AAA repair 7/6/22 but worsened the last few days prior to admission .  covid infusion? 7/22.     Pneumonia.  given roephin, azithromycin, decadron and later vancomycin and zosyn.  CT showed indeterminate age infarct  & chronic small vessel ischemic disease tPA not recommended, had carotid artery disease.  Statins held due to transaminitis.  transfered to ICU d/t acute resp failure s/p cardiac arrest apparently on 7/25/22 and he had ROSC, placed on ventilator, levophed.  AKI, AGMA,    did not improve and expired 7/30/22
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: ADMINISTERED EXPIRED VACCINE